Animal Models of Psychiatric Disorders

Mark A. Geyer* and Athina Markou
Department of Psychiatry - 0804
School of Medicine
University of California, San Diego
La Jolla, CA, 92093-0804
phone: 619-543-3582
fax: 619-543-2493
e-mail: mgeyer@ucsd.edu


REFERENCES

  1. Ahlenius S. The "Clever Hans" phenomenon in animal models of schizophrenia, or homology as an important factor in comparing behavioral functions across species. Perspectives in Biol & Med 1991;34:219-225.
  2. Bakshi VP, Swerdlow NR, Braff DL, Geyer MA. Reversal of isolation-rearing induced deficits in prepulse inhibition by Seroquel and olanzapine. Biological Psychiatry, 1998;43:436-445.
  3. Bolino F, Manna V DiCicco L, DiMichele V, Daneluzzo E, Rossi A, Casacchia M Startle reflex habituation in functional psychoses: A controlled study. Neuroscience Letters 1992;145:126-128.
  4. Boring EG The use of operational definitions in science. Psychol Rev 1945;52:243-245.
  5. Bowers MB, Freedman DX. "Psychedelic" experiences in acute psychoses. Arch Gen Psychiat 1966;15:240-248.
  6. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia: Human and animal model studies. Arch Gen Psychiatry 1990;47:181-188.
  7. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry; 1992;49:206-215.
  8. Brewin CR. Depression and causal attributions: What is their relation? Psychological Bull; 1985;98:297-309.
  9. Bridgman PW Some general principles of operational analysis. Psychol Rev 1945;52:246-249.
  10. Buckwald AM, Coyne JC, Cole CS. A critical evaluation of the learned helplessness model of depression. J Abnorm Psychol 1978;87:180-193.
  11. Cadenhead KS, Geyer MA, Braff DL. Impaired startle prepulse inhibition and habituation in schizotypal patients. Am J Psychiat 1993;150:1862-1867.
  12. Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959;56:81-105.
  13. Creese I. (editor) Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. Raven, New York, 1983.
  14. Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull 1955;52:281-302.
  15. DePablo JM, Ortiz-Caro J, Sanchez-Santed F, Guillamon A. Effects of diazepam, pentobarbital, scopolamine, and the timing of saline injection on learned immobility in rats. Physiol Behav 1991; 50:895-899.
  16. Detke MJ, Johnson J, Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Experimental and Clinical Psychopharmacology, 1997; 5:107-112
  17. Drugan RC, Skolnick P, Paul SM, Crawley JN. A pretest procedure reliably predicts performance in two animal models of inescapable stress. Pharmacol Biochem Behav 1989;33:649-654.
  18. Ellenbroek BA, Cools AR. Animal models with construct validity for schizophrenia. Behav Pharmacol 1990;1:469-490.
  19. Ellinwood EH, Sudilovsky A, Nelson L. Evolving behavior in the clinical and experimental amphetamine (model) psychoses. Am J Psychiatry 1973;130:1088.
  20. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998;393:76-79
  21. Fibiger HC, Phillips AG. Increased intracranial self-stimulation in rats after long-term administration of of desipramine. Science. 1981;214:683-685.
  22. Forbes NF, Stewart CA, Matthews K, Reid IC. Chronic mild stress and sucrose consumption: Validity as a model of depression. Physiology and Behavior 1996;60:1481-1484
  23. Freedman R, Mirsky AF. Event-related potentials: Exogenous components. In: Steinhauer SR, Gruzelier JH, Zubin J, eds. Handbook of Schizophrenia. Volume 5: Neuropsychology, Psychophysiology and Information Processing. Holland: Elsevier Science Publishers, 1991;71-90.
  24. Freedman R, Ross RG, Adler LE. Physiological indicators of the schizophrenia phenotype. Psychopharmacology: Fourth Generation of Progress--CD/ROM, New York, Raven Press 1999 in press.
  25. Geyer MA. Behavioral studies of hallucinogenic drugs in animals: Implications for schizophrenia research. Pharmacopsychiatry, 31:73-79, 1998.
  26. Geyer MA, Braff DL. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 1987;13:643-668.
  27. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 1990;25:485-498.
  28. Geyer MA, Wilkinson LS, Humby T, Robbins TW. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 1993;34:361-372.
  29. Glazer HI, Weiss JM. Long-term interference effect: an alternative to "learned helplessness". J Exp Psychol: Animal Behav Proc 1976;2:201-213.
  30. Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;24:2505-2511.
  31. Gonzalez LE, File SE, Overstreet DH. Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacology, Biochemistry and Behavior 1998;59:787-792
  32. Green AR. Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters. Neuropharmacology 1987;26:815-822.
  33. Hammen CL, Cochran SD. Cognitive correlates of life stress and depression in college students. J Abnorm Psychol 1981;90:23-27.
  34. Hinde RA. The use of differences and similarities in comparative psychopathology. In (G Serban and A Kling, eds) Animal Models in Psychobiology. pp. 187-202. New York: Plenum Press, 1976.
  35. Hollister LE. Chemical Psychoses: LSD and Related Drugs. Springfield, IL: Charles Thomas, 1968.
  36. Hume D. Treatise of human nature. 1739.
  37. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Amer J Psych 1991;148:1301-1308.
  38. Jin Y, Bunney WE, Sandman CA, Patterson JV, Fleming K, Moenter JR, Kalali AH, Hetrick W, Potkin SG. Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry 1998;43:873-878.
  39. Joyce EM. The amphetamine model of schizophrenia: A critique. Anim Models psychiat Disord. 1988;2:89-100.
  40. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacol 1993;8:315-336.
  41. Karper LP; Freeman GK; Grillon C; Morgan CA 3rd; Charney DS; Krystal JH. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J Neuropsychiatry Clinical Neurosciences, 1996, 8:60-66.
  42. Kirby LG, Chou-Green JM, Davis K, Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Research, 1997;760:218-230
  43. Kokkinidis L, McCarter BD. Postcocaine depression and sensitization of brain-stimulation reward: Analysis of reinforcement and performance effects. Pharmacol Biochem Behav 1990;36:463-471.
  44. Kornetsky C, Markowitz R. Animal models of schizophrenia. In: Psychopharmacology: A Generation of Progress Lipton MA, DiMascio A, Killam KF, eds. Raven Press, New York, 1978;583-593.
  45. Lijam N; Paylor R; McDonald MP; Crawley JN; Deng CX; Herrup K; Stevens KE; Maccaferri G; McBain CJ; Sussman DJ; et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell, 1997, 90:895-905.
  46. Lin D, Koob GF, Markou A. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward: Interactions between the two drugs. Psychopharmacology. 1999;In Press.
  47. Maier SF, Testa TJ. Failure to learn to escape by rats previously exposed to inescapable shock is partly produced by associative interference. J Comp Physiol Psychol 1975; 88:554-564.
  48. Maier SF, Seligman MEP. Learned helplessness: Theory and evidence. J Exp Psychol (Gen) 1976;1:3-46.
  49. Markou A, Koob GF. Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology 1991;4:17-26.
  50. Markou A, Koob GF. Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations. Physiol Behav 1992;51:111-119.
  51. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF. Animal models of drug craving. Psychopharmacology 1993;112:163-182.
  52. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 1998;18:135-174
  53. Matthysse S. Animal models in psychiatric research. Prog Brain Res 1986;65:259-270.
  54. McKinney WT, Bunney WE. Animal model of depression. Arch Gen Psychiatry 1969;21:240-248
  55. Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989;251:238-246.
  56. Moreau J-L, Jenck F, Martin JR, Mortas P, Haefely WE. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation in rats. Eur J Pharmacol 1992;2:43-49
  57. Mosier CI. A critical examination of the concepts of face validity. Educ Psychol Measurement 1947;7:191-205.
  58. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Brit Med J. 1987;295:681-682.
  59. O'Neil KA, Valentino D. Escapability and generalization: Effect on 'behavioral despair'. Eur J Pharmacol 1982;78:379-380.
  60. Overstreet DH. The Flinders Sensitive Line rats: A genetic animal model of depression. Neuroscience and Biobehavioral Reviews 1993;17:51-68
  61. Overstreet DH, Rezvani AH, Knapp DJ, Crews FT, Janowsky DS. Further selection of rat lines differing in 5-HT1A receptor sensitivity: behavioral and functional correlates. Psychiatric Genetics 1996;6:107-117
  62. Paylor R, Crawley JN. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology, 1997, 132:169-180.
  63. Perry W, Geyer MA, Braff DL. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry 1999, in press.
  64. Rigdon GC, Weatherspoon J. 5HT1A receptor agonists block prepulse inhibition of the acoustic startle reflex. J Pharmacol Exp Ther 1992;263:486-493.
  65. Rosenberg DE, Isbell H, Miner EJ, Logan CR. The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia 1964;5:217-227.
  66. Russell RW. The Comparative Study of Behavior. London: HK, 1951 Lewis.
  67. Schmidt CJ, Kehne JH, Carr AA. MDL 100,907: a selective 5-HT2A receptor antagonist for the treatment of schizophrenia. CNS Drug Rev 1997;3:49-67
  68. Schwarzkopf SB, Lamberti JS, Smith DA. Concurrent asessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 1993;33:806-814.
  69. Segal DS, Geyer MA. Animal models of psychopathology. In: Judd LL, Groves PM, eds. Psychobiological Foundations of Clinical Psychiatry. Philadelphia: JB Lippincott, Chapter 45, 1985.
  70. Segal DS, Geyer MA, Schuckit A. Stimulant-induced psychosis: An evaluation of animal models. In: Essays in Neurochemistry and Neuropharmacology, Vol. 5 (eds. M.B.H. Youdim, W. Lovenberg, D.F. Sharman and J.R. Lagnado), John Wiley & Sons, New York, pp. 95-130, 1981.
  71. Sipes TA, Geyer MA. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 1994, 33:441-448.
  72. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM. Genetic correlation of hippocampal auditory evoked response and alpha-bungarotoxin binding in inbred mouse strains. Neuropsychopharmacology 1996;15:152-162.
  73. Strassman RJ, Qualls CR, Berg LM. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biological Psychiatry, 1996, 39:784-795.
  74. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 1993;33:298-301.
  75. Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994;51:139-154.
  76. Swerdlow NR, Caine SB, Braff DL, Geyer MA. Neural substrates of sensorimotor gating of the startle reflex: Preclinical findings and their implications. J Psychopharmacol 1992;6:176-190.
  77. Swerdlow NR, Filion D, Geyer MA Braff DL. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biological Psychiatry, 37:286-299, 1995.
  78. Swerdlow NR, Geyer MA Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998; 24:285-301.
  79. Swerdlow NR, Keith VA, Braff DL, Geyer MA. The effects of spiperone, SCH 23390 and clozapine on apomorphine-inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 1991;256:530-536.
  80. Varty GB, Higgins GA. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacol 1995; 122:15-26.
  81. Weddington WW, Brown, BS, Haertzen CA, Cone EJ, Dax, EM, Herning RI, Michaelson BS. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psychiatry 1990;47:861-868.
  82. Weil-Malherbe H, Szara SI. The Biochemistry of Functional and Experimental Psychoses. Kugelmass IN, ed. Springfield: Charles Thomas, 1971.
  83. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-669.
  84. Weiss JM, Simson PE. Neurochemical and electrophysiological events underlying stress-induced depression in an animal model. Advances Exp Med Biol 1988;245:425-440.
  85. West AP. Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiat 1990;14:863-877.
  86. Wilkinson LS, Killcross, AS, Humby T, Hall FS, Torres EM, Geyer MA, Robbins TW. Social isolation produces developmentally specific deficits in prepulse inhibition of the acoustic startle response but does not disrupt latent inhibition. Neuropsychopharmacology 1994; 10:61-72.
  87. Willner P. The validity of animal models of depression. Psychopharmacol 1984;83:1-16.
  88. Willner P. Validation criteria for animal models of human mental disorders: Learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiat 1986;10:677-690.
  89. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacol 1987;93:358-364
  90. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997; 134:319-329
  91. Zacharko RM, Bowers WJ, Kelley MS, Anisman H. Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine. Brain Res 1984;321:175-179.

Back to Chapter

published 2000